Published in Br J Cancer on March 23, 2001
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol (2008) 1.42
Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer (2010) 1.37
Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res (2002) 1.36
Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One (2012) 1.28
Microbial dysbiosis is associated with human breast cancer. PLoS One (2014) 1.28
Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J Clin Pathol (2007) 1.18
Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol (2006) 1.16
Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer (2003) 1.11
Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One (2009) 1.06
Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer (2004) 0.99
Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res (2006) 0.97
Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol (2003) 0.95
Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS One (2012) 0.89
Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells. J Virol (2007) 0.88
Viruses and breast cancer. Cancers (Basel) (2010) 0.87
BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. Rev Med Virol (2013) 0.85
No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with breast cancer in Mexican women. Sci Rep (2013) 0.85
Is Epstein-Barr virus associated with aggressive forms of breast cancer? Br J Cancer (2011) 0.84
Cytomegalovirus and Epstein-Barr virus in breast cancer. PLoS One (2015) 0.83
Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma--another point of view. Breast Cancer Res (2003) 0.82
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer (2016) 0.81
Possible DNA viral factors of human breast cancer. Cancers (Basel) (2010) 0.79
Case report of concurrent primary malignancies of the breast and nasopharynx. Oncol Lett (2012) 0.78
Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors. PLoS One (2014) 0.77
Role of the microbiome in non-gastrointestinal cancers. World J Clin Oncol (2016) 0.76
Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation. EBioMedicine (2016) 0.76
Outcome of Epstein-Barr virus-associated primary breast cancer. Mol Clin Oncol (2014) 0.76
Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response. BMC Cancer (2014) 0.76
Association of Epstein-Barr virus infection and breast carcinoma. Arch Med Sci (2013) 0.75
Absence of Epstein-Barr virus EBER transcripts in male breast cancer. Virchows Arch (2005) 0.75
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol (2000) 29.28
Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst (1999) 4.94
Viruses in human cancers. Science (1991) 4.58
Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol (1987) 3.53
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol (1992) 1.75
Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer (1998) 1.24
Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours. Int J Cancer (1997) 1.09
Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol (1995) 1.09
Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer (1977) 1.08
Carcinoma of stomach and breast with lymphoid stroma: localisation of Epstein-Barr virus. J Clin Pathol (1994) 1.08
Re: detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst (2000) 1.05
Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull (1981) 1.01
Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol (1994) 1.00
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol (1993) 0.98
Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation. J Pathol (1994) 0.97
Thyroid hormone regulation of peptidylglycine alpha-amidating monooxygenase expression in anterior pituitary gland. Mol Endocrinol (1990) 0.96
Cancer mortality among north African migrants in France. Int J Epidemiol (1996) 0.93
Breast cancer in women under 30 years of age. Breast Cancer Res Treat (1985) 0.91
Developmental regulation of peptidylglycine alpha-amidating monooxygenase (PAM) in rat heart atrium and ventricle. Tissue-specific changes in distribution of PAM activity, mRNA levels, and protein forms. J Biol Chem (1989) 0.87
Increased risk of nasopharyngeal carcinoma among males of French origin born in Maghreb (north Africa). Int J Cancer (1993) 0.85
DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer? Int J Cancer (1997) 0.81
Cancer incidence in young offspring of Jewish immigrants to Israel. A methodological study. I. Nasopharyngeal malignancies and Ewing sarcoma. Cancer Detect Prev (1990) 0.79
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
The reactions of patients to a video camera in the consulting room. J R Coll Gen Pract (1984) 3.71
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J (1989) 3.17
Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences. Eur J Cancer (1994) 2.80
High-performance high-TC superconducting wires. Science (2006) 2.69
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci U S A (1986) 2.66
Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol Lett (1996) 2.53
The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev (1992) 2.44
Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology (1978) 2.42
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2003) 2.31
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS (1994) 1.99
Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer (1996) 1.97
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer (2006) 1.96
Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS (1998) 1.95
Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst (1980) 1.93
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 1.93
Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury. Clin Infect Dis (2001) 1.90
Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84
The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. J Virol (1989) 1.79
Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. J Virol (1992) 1.75
Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis (1994) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]. Bull Cancer (1991) 1.63
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol (1987) 1.59
c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res (1992) 1.59
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer (1999) 1.55
Changes in psychological diagnosis and prescription in a practice employing a counsellor. Fam Pract (1985) 1.55
Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J Natl Cancer Inst (2000) 1.54
Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res (1991) 1.53
Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res (1987) 1.53
Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer (1995) 1.51
Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) (1998) 1.50
[Spontaneous remission of breast cancer. A literature review]. Ugeskr Laeger (1999) 1.48
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum. J Gen Microbiol (1981) 1.46
Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). J Virol (1977) 1.44
Personality styles of patients asserting environmental illness. J Occup Med (1990) 1.44
Spot position of rat liver ribosomal proteins by four different two-dimensional electrophoreses in polyacrylamide gel. Mol Gen Genet (1979) 1.44
Asomatognosia P. Bonnier. L'aschématie. Revue Neurol 1905;13:605-9. Epilepsy Behav (2009) 1.44
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer (1994) 1.43
The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival. Eur J Clin Chem Clin Biochem (1995) 1.42
The impact of pancreas transplantation on kidney allograft survival. Am J Transplant (2011) 1.42
Re: Prognostic importance of low c-erbB2 expression in breast tumors. J Natl Cancer Inst (1999) 1.41
HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis (2001) 1.41
[Use of Q10 in cancer patients]. Ugeskr Laeger (1994) 1.39
[Characterization of the anti-cytokeratin monoclonal antibody KL1 by bidimensional electrophoresis followed by immunodetection]. Ann Pathol (1992) 1.39
[The chondrocranium of an 18 mm human embryo. A 3-dimensional computer-assisted reconstruction]. Rev Stomatol Chir Maxillofac (1999) 1.39
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]. Cancer Radiother (2002) 1.39
Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys (1993) 1.38
[Chemotherapy in metastasing breast cancer--is it beneficial?]. Ugeskr Laeger (1994) 1.38
Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer (2010) 1.37
The importance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol (1998) 1.37
Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis (1989) 1.37
Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway. J Virol (2000) 1.33
Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer (1997) 1.33
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Cancer Res (1987) 1.32
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32
Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant (2007) 1.31
Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol (1993) 1.31
Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer (1997) 1.29
Reappraisal of breast hamartomas. A morphological study of 41 cases. Pathol Res Pract (1994) 1.29
Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer (1995) 1.27
Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer (1999) 1.27
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia (2005) 1.27
Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur J Cancer (1992) 1.26
Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HR1-superinfected Raji cells. J Virol (1977) 1.26
EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol (2008) 1.25
A comparison of synchronization filters in different auditory receptor organs. Hear Res (1988) 1.24
Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res (1986) 1.23
Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. J Gen Virol (1993) 1.22
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology (2001) 1.22
Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem (2000) 1.22
Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology (2004) 1.21
Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival. Br J Cancer (2006) 1.21
Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol (1990) 1.21
Income of living kidney donors and the income difference between living kidney donors and their recipients in the United States. Am J Transplant (2012) 1.20
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res (1995) 1.19
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line. Science (1983) 1.19
Estradiol dependence of the specific mammary tissue targeting of polyoma virus oncogenicity in nude mice. Oncogene (1990) 1.19
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Oncogene (2006) 1.16